Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (15)
- Safety monitoring and information (10)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Legislation (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- Weight loss products (1)
Collection content
109 result(s) found, displaying 71 to 80
-
PageSerious Scarcity Substitution Instrument allows pharmacists to dispense 180 mg capsules without a new prescription.
-
FormsForms for notifying the TGA of a change in sponsorship.
-
CommitteeInformation on the role and membership of ACM and proposed meeting dates.
-
FormsUpdated form used to notify us of proprietary ingredient mixtures for use in therapeutic goods.
-
User guideInformation on how to compile a literature based submission (including mixed applications).
-
User guideHow to search TGA business services for approved ingredients and accepted TGA terminology.
-
User guideThis document replaces AU eCTD specification - Module 1 and regional information Version 3.0 and contains updated information.
-
FormsFind out what process to follow if a product is manufactured using a human embryo or a human embryonic stem cell, or any material sourced from such an embryo or stem cell.
-
FormsSponsors can use this form to apply for an additional trade name for a registered prescription medicine, under section 23 of the Therapeutic Goods Act 1989.
-
FormsUse this form for Category 1 and Comparable Overseas Regulator (COR) report-based prescription medicines applications, or variations.